G - Physics – 01 – N
Patent
G - Physics
01
N
167/37, 195/1.11
G01N 33/577 (2006.01) A61K 39/395 (2006.01) C07K 16/30 (2006.01) C12N 5/02 (2006.01)
Patent
CA 1221648
ABSTRACT The invention relates to a monoclonal antibody F23, and its use in identifying or characterizing human renal cancer antigen. The invention is also concerned with an F23 antibody producing hybridoma cell line formed by fusing a myeloma derived cell strain and splenocytes derived from BALB/c mice immunized with established culture lines of renal cancer. F23 mAb becomes part of a screening panel for human renal cancer which includes seventeen other mAbs. These mAbs subset the normal human nephron and distinguish renal cancers. F23 is also part of a uro-panel of seven mAbs which subset the human urinary system and screen for cancers of said system.
449205
Bander Neil H.
Cordon-Cardo Carlos
Finstad Connie L.
Fradet Yves
Lloyd Kenneth O.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Sloan-Kettering Institute For Cancer Research
LandOfFree
Monoclonal antibodies to human renal cancer antigens and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies to human renal cancer antigens and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to human renal cancer antigens and method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1181930